Evidence shows reductions in fluoroscopy time and radiation exposure of up to 90%

Article

Cardiac Resynchronization Therapy (CRT) device implantations are often associated with high radiation dose exposure due to long procedure and fluoroscopy times.

A first in human study recently conducted at the Heart Centre Leipzig (Germany) proved the benefits of using a novel sensor-based MediGuide™ Technology (St. Jude Medical Inc., St. Paul, MN) in combination with the Artis zee angiography system (Siemens Healthcare, Forchheim, Germany) for CRT implantations [1].

The study showed reductions fluoroscopy time and radiation exposure of up to 90% when compared to conventional (exclusively fluoroscopy-guided) CRT implantations. There were no negative consequences on procedural efficacy and no complications.

 

Click here to access this White Paper.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.